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   Ninety－eight patients have been treated by regular dialysis during 10 years period， 1968 to 1977．
In order to prevent hyperphosphatemia， phdsphqte－binding antiacid drug has been administered and
calciurn content of dialysate （Dca） was increased fi”om 5 to 7．5 mg9・Xo．
   C－terminal PTH value showed as twice as normal but N－terminal PTH was normal when Dca
was 5 mge／．． lrr？．mediately after Dca was changed to 7 mgO／，， N－terminal PTH tr一 ansiently rose and
soon returned to normal value． C－terminal PTI showed remarkab’ ie decrease returning to the normal
range． CT was always normal despite change of Dca． Vitamin D3 and 25－HCC level were normal，
24・， 25－DHCC was． low， and 1， 25’ 一DHCC was also low in hemodialysis cases． These substances were
almost undetectable in anephric cases．
   Cortical thickness of the clavicula of the patients did not show a significant difference from that
of the healthy control’垂?窒唐盾獅刀D MCI also did not show any change during the course of dialysis． lf
limited to 20 cases who have been treated by hemodialysis more than 5 year：．， bone x－ray films showed
osteal resorption in 6， demineraiization in 4， osteosclerosis in 1． NTeither fracture nor vascular calcifi－
catien was observed．
   As mentioned above， calciu皿metabolism has been rather well contro11ed under our dialysis pro．
gram in which BUN and creatinine were maintained at the relatively low level by dialysis performed
for suMcient time．
   Causative factors of calcium metabolism disorder皿ight be metabolic disturbance of vitamin D
and phosphate retention． A participation of some kind of uremic toxins should be also considered．















































 透析条件は，Kiil型， coil型， HFAK型の透析
器を用い，週12～24時間透析を行ない，三流液とし
ては，キンダリー2号液（Na：132 mEq／l・， Ca：2．5
mEqfL， K：2．O mEq／L， Mg：1 ．5 mEq／L，酢酸塩：
33mEq／L，ブドウ糖：200 mg％）を使用し，1976年
2月以後はキンダリー3号液（Na：132 mEq／L， Ca：
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Fig． 1． Serum BUN and creatinine levels in patients with regular dialysis treatment．
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Fig． 2．
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Serurr｝ calcium， phosphorus， Ca－P products and alkali－phosphate
levels in patients with regular dialysis treatment．
 （2）血清Ca， P， A1－P値
 Ca代謝障害の生化学的指標として透析前値の血清
Ca， P， Ca－P積， Al－P値をFig．2に示す．1973年
の平均で血清Ca値は7．96・ng％，血清P値は7．21









mg％， Ga－P積53．8， A1－P値122 mu／m1となり，
1978年では血清Ca値8．64 mg％，血清P値5・33





























Changes in the blood levels of PTA and CT in
paticnts with regular dialysis treatment．
1251
Treatment DatePTHI．34 PTHI－s4 CT
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 測定したPTHI．．34， CTと血清Ca， P， Ca－P積
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Fig． 5． Relation between Al－P and CTfPTHi－34 in
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Fig． 6． Relation between PTHi．．34 and CT i］ patients with
    regular dialysis treatment （R．D．T）．
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Fig． 7． Cortical thickness of clavicula in
    patients with regular dialysis treatment
    （closes circle： before 5 years dialKsis，
    open circle： over 5 years dia1ysis）．
Table 8． Cortical thickness of clavicula in patients
    with regular dialysis treatment






































的所見はBUN 180 mg％， creatinine 21．2 mg％，血
清P20．5mg％とunder－dialysisの状態が続いていた
ものと考えられた．Almi－gel⑧投与により高P血症の
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Fig． 8． ％ cortical thickness of clavicula and duration
     of regular dialysis treatment．
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Fig． 9． Changes of metacatpal index patients with
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Fig． 10． Bone miueral contents of patients with
    regular dialysis treatment．
であるが，（〕ase 14は1976年，1977年には2・05，5・O
ng／mlと高値を示していた．逆に骨吸収像の悪化した




















































X－ray abnormalities of bone in patients with
regular dialysis treatment．
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Cロse Sex Start of R，D，T， X－r〔1y  （1bnorma正ity
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Fig． 11．
隷離
Periosteal resorption in case 3 and case 18．




















5A； case 5． Osteoporosis （1972） 5B； Rugger－Jersey spine （1978）
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Fig． 13． lmprovement of bone resorption
    IA， 14A： intraosteal resorption （Brown tumor） （1972）
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Case 9， 9A： periarticular calification．
9B： improved after 1 month． 9： vasculer calcification
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Fig， 15，Bone scintigram by
ggmTc－MDP of case 19．
This show abnormal
pulmonary uptake．
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鵬SEく
GFRJ． 一 serum plr一一一D， serum caj， 一一一一i pTHT 一一一〉 osteitis fibrosa
1，25－D狽gCC」． 一 Ca abEorption 」，
 Osteomalacia
Fig． 16 Schematic flow diagram to show current hypothesis fow the pathogenesfis
    of renal osteodystrophy．
  Fig． 16． S¢hematic fiow diagram to show current hypothesis fow
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ることが充分に考えられ，われわれがBUN 80～100
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